BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP
181 results:

  • 1. Elevated FBXL6 activates both wild-type KRAS and mutant KRAS
    Xiong HJ; Yu HQ; Zhang J; Fang L; Wu D; Lin XT; Xie CM
    Mil Med Res; 2023 Dec; 10(1):68. PubMed ID: 38124228
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Hereditary succinate dehydrogenase-deficient renal cell carcinoma.
    Rogala J; Zhou M
    Semin Diagn Pathol; 2024 Jan; 41(1):32-41. PubMed ID: 37981479
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Eicosapentaenoic acid enhances the sensitivity of osteosarcoma to cisplatin by inducing ferroptosis through the DNA-PKcs/AKT/NRF2 pathway and reducing PD-L1 expression to attenuate immune evasion.
    Zhang Y; Shen G; Meng T; Lv Z; Li X; Li J; Li K
    Int Immunopharmacol; 2023 Dec; 125(Pt B):111181. PubMed ID: 37951196
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Morphological, immunohistochemical, and genetic analyses of epithelioid gastrointestinal stromal tumors.
    Shi J; Sun K; Kong F; Shen D
    Ann Diagn Pathol; 2023 Dec; 67():152208. PubMed ID: 37696133
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Malignant peripheral nerve sheath tumor: a clinicopathological analysis].
    Peng W; Gong QX; Fan QH; Liu Y; Song GX; Wei YZ
    Zhonghua Bing Li Xue Za Zhi; 2023 Sep; 52(9):924-930. PubMed ID: 37670622
    [No Abstract]    [Full Text] [Related]  

  • 6. REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial.
    Martin-Broto J; Valverde C; Hindi N; Vincenzi B; Martinez-Trufero J; Grignani G; Italiano A; Lavernia J; Vallejo A; Tos PD; Le Loarer F; Gonzalez-Campora R; Ramos R; Hernández-Jover D; Gutierrez A; Serrano C; Monteagudo M; Letón R; Robledo M; Moura DS; Martin-Ruiz M; López-Guerrero JA; Cruz J; Fernandez-Serra A; Blay JY; Fumagalli E; Martinez-Marin V
    Mol Cancer; 2023 Aug; 22(1):127. PubMed ID: 37559050
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mechanism and therapeutic implications of pomalidomide-induced immune surface marker upregulation in EBV-positive lymphomas.
    Jaeger HK; Davis DA; Nair A; Shrestha P; Stream A; Yaparla A; Yarchoan R
    Sci Rep; 2023 Jul; 13(1):11596. PubMed ID: 37463943
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A short peptide LINC00665_18aa encoded by lncRNA LINC00665 suppresses the proliferation and migration of osteosarcoma cells through the regulation of the CREB1/RPS6KA3 interaction.
    Pan J; Liu M; Duan X; Wang D
    PLoS One; 2023; 18(6):e0286422. PubMed ID: 37285335
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The FBXO32/ATR/ATM axis acts as a molecular switch to control the sensitivity of osteosarcoma cells to irradiation through its regulation of EXO1 expression.
    Lu Y; Huang P; Li Y; Liu W; Li J; Zhao R; Feng H; Shi C; Cao G
    Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):842-852. PubMed ID: 37227155
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. HSP90-regulated CHIP/TRIM21/p21 Axis Involves in the Senescence of Osteosarcoma Cells.
    Xu GS; Lin YN; Zeng Q; Li ZP; Xiao T; Ye YS; Li ZY; Gao X
    Protein Pept Lett; 2023; 30(6):513-519. PubMed ID: 37211848
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Surgical Management of Germline Gastrointestinal Stromal Tumor.
    Kwak HV; Tardy KJ; Allbee A; Stashek K; DeMatteo RP
    Ann Surg Oncol; 2023 Aug; 30(8):4966-4974. PubMed ID: 37115371
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome?
    Solhusløkk Höse K; Stenman A; Svahn F; Larsson C; Juhlin CC
    Endocr Pathol; 2023 Mar; 34(1):129-141. PubMed ID: 36656469
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Preferential
    Giger OT; Ten Hoopen R; Shorthouse D; Abdullahi S; Bulusu VR; Jadhav S; Maher ER; Casey RT
    J Clin Pathol; 2023 Dec; 77(1):34-39. PubMed ID: 36198483
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcoma.
    Du M; Gu J; Liu C; Liu N; Yu Z; Zhou C; Heng W; Cao Z; Wei F; Zhu K; Wang Y; Zhang W; Xue X; Zhang Y; Qian J
    J Exp Clin Cancer Res; 2022 Apr; 41(1):154. PubMed ID: 35459258
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MicroRNA-101-3p Modulates Mitochondrial Metabolism via the Regulation of Complex II Assembly.
    Ziemann M; Lim SC; Kang Y; Samuel S; Sanchez IL; Gantier M; Stojanovski D; McKenzie M
    J Mol Biol; 2022 Jan; 434(2):167361. PubMed ID: 34808225
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. TGF-β protects osteosarcoma cells from chemotherapeutic cytotoxicity in a sdh/HIF1α dependent manner.
    Xu Y; Li Y; Chen X; Xiang F; Deng Y; Li Z; Wei D
    BMC Cancer; 2021 Nov; 21(1):1200. PubMed ID: 34763667
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis.
    Schmidt O; Nehls N; Prexler C; von Heyking K; Groll T; Pardon K; Garcia HD; Hensel T; Gürgen D; Henssen AG; Eggert A; Steiger K; Burdach S; Richter GHS
    J Exp Clin Cancer Res; 2021 Oct; 40(1):322. PubMed ID: 34654445
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response.
    Yebra M; Bhargava S; Kumar A; Burgoyne AM; Tang CM; Yoon H; Banerjee S; Aguilera J; Cordes T; Sheth V; Noh S; Ustoy R; Li S; Advani SJ; Corless CL; Heinrich MC; Kurzrock R; Lippman SM; Fanta PT; Harismendy O; Metallo C; Sicklick JK
    Clin Cancer Res; 2022 Jan; 28(1):187-200. PubMed ID: 34426440
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study.
    Kim J; Gianferante M; Karyadi DM; Hartley SW; Frone MN; Luo W; Robison LL; Armstrong GT; Bhatia S; Dean M; Yeager M; Zhu B; Song L; Sampson JN; Yasui Y; Leisenring WM; Brodie SA; de Andrade KC; Fortes FP; Goldstein AM; Khincha PP; Machiela MJ; McMaster ML; Nickerson ML; Oba L; Pemov A; Pinheiro M; Rotunno M; Santiago K; Wegman-Ostrosky T; Diver WR; Teras L; Freedman ND; Hicks BD; Zhu B; Wang M; Jones K; Hutchinson AA; Dagnall C; Savage SA; Tucker MA; Chanock SJ; Morton LM; Stewart DR; Mirabello L
    JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 34308104
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Iron Chelator Induces Apoptosis in Osteosarcoma Cells by Disrupting Intracellular Iron Homeostasis and Activating the MAPK Pathway.
    Xue Y; Zhang G; Zhou S; Wang S; Lv H; Zhou L; Shang P
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281233
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.